Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 09627Y109

Event date: 2015-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,488,248
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-028799
Form type
SC 13G
Filer
Blueprint Medicines Corp
CIK
CIK 1597264
Filed
May 08, 2015
Reporting period
Apr 30, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub